检索结果 - Meiting Chen
- Showing 1 - 10 results of 10
-
1
-
2
-
3
-
4
-
5
-
6
-
7
HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study 由 Meiting Chen, Kai Yao, Manming Cao, Hao Liu, Cong Xue, Tao Qin, Lingru Meng, Zhousan Zheng, Zike Qin, Fangjian Zhou, Zhuowei Liu, Yanxia Shi, Xin An
出版 2023Artigo -
8
Bevacizumab, tislelizumab and nab-paclitaxel for previously untreated metastatic triple-negative breast cancer: a phase II trial 由 Meiting Chen, Riqing Huang, Qixiang Rong, Wei Yang, Xiujiao Shen, Qi Sun, Ditian Shu, Kuikui Jiang, Cong Xue, Jing Peng, Xin An, Haifeng Li, Fei Xu, Yanxia Shi
出版 2025Artigo -
9
-
10
相关主题
Medicine
Biology
Internal medicine
Biochemistry
Cancer
Cancer research
Gene
Breast cancer
Immunology
Oncology
Adverse effect
Anemia
Cell biology
Chemistry
Chemotherapy
Genetics
Metastatic breast cancer
Molecular biology
Analytical Chemistry (journal)
Antibody
Antibody-drug conjugate
Apoptosis
Bacterial outer membrane
Beta oxidation
Bevacizumab
CCL2
CCR2
Carcinoma
Chemokine
Chemokine receptor